Register Now
Youtube Linkedin Facebook
dxpx logo white

Medtech Investor Conference Program

It’s time to get excited for the next DxPx US Conference in the heart of the ADLM in Chicago, IL!

Join us for four days packed with industry insights, exhibits from the most innovative startups, the 42PLUS1 Pitch Competition,
and hundreds of one-to-one meetings from July 29th – August 1st. 

During all 4 days:

One-to-one partnering + access to the Startup City

We look forward to seeing you at DxPx US!

Speakers and moderators:

To be announced soon!

The DxPx US Conference:

DxPx is the only partnering conference dedicated to Diagnostics, Digital Health, Precision Medicine, and Life Sciences Tools. Now considered the “World Series” of partnering events, for the past four years we have been able to bring people together to build long-lasting partnerships with startups, accelerators, industry leaders, and investors.

benefits

Benefits of joining:

  • Schedule one-to-one meetings with relevant target groups including growth companies, investors, and decision makers.
  • Promote your innovation to industry leaders and showcase your products or services in person or virtually.
  • Learn from pioneers and disruptors in the industry and experience knowledge transfer at the highest level through our panel discussions and fireside chats.
  • Explore financing, licensing, and M&A opportunities.
  • Submit a pitch and have it reviewed by our Executive Jury. The most promising applicants will earn the opportunity to formally pitch their business and compete for up to $2 million in funding as part of our 42PLUS1 Pitch Award.
  • Be part of DxPx US’s Startup City, where innovative startups and growth companies get their own booth space to showcase their business.

One-to-one investor partnering and networking:

This is the heart and soul of DxPx. 

Find your next collaborator through our professional digital partnering tool and schedule one-to-one meetings in advance to discuss financing, co-development, licensing, and M&A opportunities. 

Our improved digital partnering tool will select relevant partners for you via keywords, an A.I.-based algorithm, and a smart search engine, so you can use your time more efficiently and facilitate dealmaking more easily.

At our conference venue, there are one-to-one meeting cubicles to hold your pre-scheduled business meetings in private and without distraction. Global networking, made easy!

one-to-one-partnering-eu-2021

Want to support us?

Reach out to learn more about the opportunities & benefits we offer via our sponsorship packages.
Send us a message
DxPx US

DxPx Conference Date & Location:

Four Days In-Person
July 29 – August 1, 2024 in Chicago, IL – in the heart of the ADLM

Two Weeks of Digital Partnering
Announcing soon!

Plan your trip:

Travel and other information:

Together with our strong partners and active life science investors we have created a precisive solution to reach your financial milestones. Attract and network with world’s leading KOLs who know and understand your industry – not just various service providers – at DxPx US.

mccormick place night

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience